Oct 5, 2017

Report: Trump plans to decertify Iran deal

Trump speaks at the Las Vegas Metropolitan Police Department. Photo: Evan Vucci / AP

Trump has plans to decertify the 2015 Iran nuclear deal, according to "people briefed on an emerging White House strategy for Iran," per The Washington Post.

What it means: The deal has eased Iran off sanctions in exchange for a rolled-back nuclear program, so this could set the U.S. on a path to sanction Iran and amp up tensions between Tehran and D.C. And Tehran has said it could start up its nuclear program within days, raising a potential additional nuclear problem for Trump in addition to North Korea. Ultimately, the decision would be kicked to Congress.

The disagreement: Mattis said earlier this week he thought it would be in U.S. security interests to remain in the deal, although today White House Press Secretary Sarah Sanders said Trump's national security team is "supporting" his decision and to expect an announcement in "days." Sanders elaborated that "the president has, as he said, made a decision on this and he'll make that announcement at the appropriate time. The main focus that he has had has been a comprehensive strategy on how to deal with Iran."

Those briefed on the matter told The Washington Post the plans still may change, but keep in mind Trump has been railing against the deal for some time now as a bad deal for the U.S.

Go deeper

Pandemic forces startups to shift gears

Illustration: Eniola Odetunde/Axios

Spaces CEO Brad Herman had an early warning about COVID-19 because his startup supplies VR attractions to a number of theme parks in China. Realizing that the business he spent the last few years building was going to evaporate, Herman quickly found a new way to apply his team's know-how: helping companies host Zoom teleconferences in VR.

Why it matters: Many startups are rethinking the viability of their core businesses in the wake of the coronavirus. Spaces' move is one of many such pivots likely to crop up in the coming months.

International coronavirus treatment trial uses AI to speed results

Hydroxychloroquine is one of the drugs that will be included in the trial. Photo: John Philips/Getty Images

The first hospital network in the U.S. has joined an international clinical trial using artificial intelligence to help determine which treatments for patients with the novel coronavirus are most effective on an on-going basis.

Why it matters: In the midst of a pandemic, scientists face dueling needs: to find treatments quickly and to ensure they are safe and effective. By using this new type of adaptive platform, doctors hope to collect clinical data that will help more quickly determine what actually works.

Go deeperArrow44 mins ago - Health

We can't just flip the switch on the coronavirus

Illustration: Sarah Grillo/Axios

It feels like some big, terrible switch got flipped when the coronavirus upended our lives — so it’s natural to want to simply flip it back. But that is not how the return to normalcy will go.

The big picture: Even as the number of illnesses and deaths in the U.S. start to fall, and we start to think about leaving the house again, the way forward will likely be slow and uneven. This may feel like it all happened suddenly, but it won't end that way.

Go deeperArrow58 mins ago - Health